TEMENOS
15.1.2020 08:02:08 CET | Business Wire | Press release
- Larger banks can now renovate their core banking applications component by component without compromising their end goal of a full system transformation to a cloud-agnostic, cloud-native architecture. Temenos Transact microservices architecture enables continuous change with tangible business benefits at every stage.
- Temenos Transact microservices - such as accounts and deposits, and retail lending - can be integrated through APIs in any sequence with any legacy infrastructure, quickly and safely, helping banks to unlock the power of digital transformation.
- Temenos offers banks a real choice of transformation strategies, from continuous renovation where larger banks replace components of their architecture one at a time to ‘build and renovate’ - where they can build a new digital stack while continuously migrating products and customer bases from their legacy systems.
- Temenos Transact microservices can deliver enterprise-wide capabilities such as pricing on top of legacy infrastructures as a first step toward creating value for the bank. For a complete digital banking transformation, Transact works in conjunction with microservices-based Temenos Infinity.
- Temenos Transact is built on cloud-native, cloud-agnostic technology that enables banks to significantly reduce their total cost of ownership through elastic cloud scalability, distributed database technology and multi-cloud resilience, all underpinned by the benefits of vendor and platform independence
Temenos (SIX: TEMN), the banking software company, announced that it has reached a major milestone in the delivery of its microservices-based architecture for cloud-native, cloud-agnostic Temenos Transact. This unlocks the potential for Tier 1 banks to strategically transform their core banking systems at scale.
Large banks are burdened by their legacy infrastructures. The cost and associated risk of replacing these complex systems, which have been customized over decades, is high. However, these outdated systems are making banks suffer high operational costs, high risk of outages, and a lack of agility that prevents them from bringing innovative, personalized products to market. The urgency to digitally transform has never been greater.
Temenos is now accelerating the roll-out of its microservices to help larger banks continuously transform their core banking applications. Unlike traditional monolithic core banking systems, Temenos Transact has independently deployable components that support continuous renovation based on the bank’s business needs. For the first time, there is now an alternative for banks to safely update critical elements of their core banking systems one component at a time with proven cloud-native, cloud-agnostic software and see tangible benefits along the way. These microservices can be deployed independently, enterprise wide and banks can retain existing systems where they are fit for purpose. Combined with microservices-based Temenos Infinity, banks have an agile, services based architecture for both core banking and digital customer journeys. This offers an alternative to the already successful build and migrate implementation approach, where banks can build a new digital stack while continuously migrating products and customer bases from their legacy systems.
Banks can pursue a long-term strategic roadmap while continuously renovating product lines, such as deposits and accounts, and core systems such as funds authorization and position keeping, based on their commercial and operational priorities. This strategy enables banks to flex the sequence of renovation as priorities change over time.
Temenos’ microservices strategy offers existing Temenos Transact clients the benefit of granular upgrades, allowing them to react to market opportunities faster while cutting the total cost of ownership of their existing core banking platform. Leveraging Temenos Continuous Deployment , which extends the Temenos DevOps operations into banks’ own environments, Temenos clients can accelerate the speed of software delivery and rapidly bring competitive innovations to market.
For smaller banks, the recommended approach is to select Temenos Transact as a SaaS offering to speed deployment and simplify IT operations.
Building on its extensive set of standalone services - such as Payments, Financial Crime Mitigation, Enterprise Data Management and Analytics - Temenos now offers new standalone banking microservices including:
- Accounts and Deposits: this service manages all the activities in the life of current, checking and deposit accounts in real time. Feature-rich, it supports any currency and offers a great variety of interest calculation methods and configurable business rules and events. Fully automated, the service integrates seamlessly through APIs with distribution services and other core systems such as payments, pricing, accounting. Deployed as a microservice, it leverages the cloud’s elastic scalability to manage millions of accounts with the lowest TCO.
- Retail Lending: this service manages a wide range of lending products, from simple unsecured consumer loans in any currency to complex facilities including multiple loans and associated collateral requirements. Designed for real-time processing and highly configurable, Retail Lending is rich and flexible enough to replace a number of legacy systems within the bank. Through APIs, it will integrate with the rest of the IT ecosystem, in the cloud or on premise.
- Enterprise product : a standalone product catalogue that enables banks to design and take to market products on a single system, reducing cost and boosting profitability of products. The service enables financial institutions to centralize all product definitions in a common repository, giving them greater overview and control across multiple business lines often working in silos. It helps banks launch new products and commercial offers much faster.
- Enterprise pricing: a central pricing engine that supports greater personalization of products services driven by AI, and improves time to market for all product types, including bundled products, relationship-based pricing and third-party products. Banks can get greater control over the fees they apply, often within disconnected applications. This increases profitability for the banks. With relationship pricing, they are able to define granular rules based on the client’s characteristics and the context of a transaction, and thus offer a personalized banking experience to each customer.
Temenos Transact microservices are functionally rich, enabling fast deployment without the need to build additional capabilities on top. Temenos has created reusable country Model Banks, which include regulatory compliance and best business practice solutions, for more than 150 countries. This helps banks go live faster and acts as a foundation for future innovation.
Max Chuard, Chief Executive Officer, Temenos, said : "To date, larger banks have been shying away from digital transformation projects. As the #1 banking software company, we are taking the lead in bringing about industry change. We are delivering the Temenos Transact microservices architecture, which will revolutionize banking. This microservices-based cloud architecture enables large banks to finally unlock their potential by transforming their core banking applications rapidly and at scale. Larger banks can renovate their core banking applications without compromising their end goal of a full digital transformation to a cloud-agnostic, cloud-native architecture, one component at a time. This is an alternative to the already successful build and migrate approach where, banks can build a new digital stack while continuously migrating products and customer bases from their legacy systems.
"We have a proven track record of helping banks to digitally transformation. Our high-performing clients using Temenos software have achieved industry-leading cost-income ratios of 25.2% and returns on equity of 25.0%, 2X better than the industry average. Only Temenos has the advanced technology and depth of banking expertise and to deliver this."
Temenos Transact microservices leverage cloud-native, cloud-agnostic technology to improve efficiency by allowing banks to scale quickly and elastically while benefiting from multi-cloud resilience. Temenos gives banks freedom of choice to deploy software on premise, in any public cloud, or as a Temenos SaaS.
- Ends –
About Temenos
Temenos AG (SIX: TEMN), headquartered in Geneva, is the world’s leader in banking software, partnering with banks and other financial institutions to transform their businesses and stay ahead of a changing marketplace. Over 3,000 banks across the globe, including 41 of the top 50 banks, rely on Temenos to process both the daily transactions and client interactions of more than 500 million banking customers. Temenos offers cloud-native, cloud-agnostic front office and core banking, payments, fund management and wealth management software products enabling banks to deliver consistent, frictionless customer journeys and gain operational excellence.
Temenos software is proven to enable its top-performing clients to achieve industry-leading cost-income ratios of 25.2% and returns on equity of 25.0%, 2X better than the industry average. These clients also invest over 53% of their IT budget on growth and innovation versus maintenance, which is 2.5X the industry average, proving the banks’ IT investment is adding tangible value to their business.
For more information, please visit www.temenos.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200114005069/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Industrial Decarbonization: Calderion, WenCo and Terravent Invest in Graforce to Scale Plasma Pyrolysis Globally25.2.2026 08:07:00 CET | Press release
The investor consortium comprising the Paris-based Next Generation Fuels Industrial & Technological fund Calderion (Audacia), alongside infrastructure developer Terravent and WenCo Family Office, announces the closing of a strategic double-digit million-euro financing round for Berlin-based Graforce GmbH. The investment is dedicated to the industrial scale-up of Graforce’s proprietary plasma pyrolysis technology, addressing the growing global demand for cost-efficient low-carbon hydrogen, syngas, and carbon removal solutions that are compatible with existing industrial infrastructures. Disruptive alternative to conventional processes Graforce’s technology aims at replacing CO₂-intensive legacy routes such as steam reforming and classical gasification. By applying plasma to methane, biogas, flare gas, and landfill gas, the process converts these streams into their valuable molecular components instead of emitting them. The result is a high-efficiency production of clean hydrogen and syn
Mevion Medical Systems Announces CE Marking of the MEVION S250-FIT™ Proton Therapy System, Expanding Global Access to Compact Proton Therapy25.2.2026 08:00:00 CET | Press release
CE Marking enables marketing and clinical use of the world’s first and only LINAC vault-ready proton therapy system across the European Union Mevion Medical Systems, the global leader in compact proton therapy, today announced that the MEVION S250-FIT Proton Therapy System has successfully completed the conformity assessment process and has received CE Marking under Regulation (EU) 2017/745 (EU MDR). This regulatory milestone enables the marketing, sale, and clinical use of the MEVION S250-FIT system throughout the European Union, building on the system’s existing U.S. FDA 510(k) clearance granted in September 2025. The MEVION S250-FIT is the first and only proton therapy system designed to fit into a standard radiation therapy vault. By enabling cancer centers to use their existing infrastructure, the MEVION S250-FIT dramatically reduces the cost, complexity, and timeline traditionally associated with proton therapy adoption. This opens a new pathway for hospitals and cancer centers a
Bureau Veritas:Sector-Leading Organic Revenue Growth of 6.5% in FY 202525.2.2026 07:30:00 CET | Press release
Strong margin improvement to 16.3% in FY 2025Positive growth outlook with continued margin expansion in 2026New EUR 200 million share buyback Bureau Veritas (BOURSE:BVI): 2025 key figures1 › Full-year revenue of EUR 6,466.4 million, up 6.5% organically (with 6.3% organic growth in Q4). At constant currency, the growth was up 7.3% year-on-year and up 3.6% on a reported basis, › Adjusted operating profit of EUR 1,052.9 million, up 5.7% versus EUR 996.2 million in FY 2024, representing an adjusted operating margin of 16.3%, up 32 basis points year-on-year and up 51 basis points at constant currency, › Operating profit of EUR 992.4 million, up 6.3% versus EUR 933.4 million in FY 2024, › Adjusted net profit of EUR 631.4 million, up 1.7% versus EUR 620.7 million in FY 2024, › Adjusted EPS stood at EUR 1.42 in 2025, with a 2.8% increase versus FY 2024 (EUR 1.38 per share) and up 9.2% at constant currency, › Attributable net profit of EUR 588.0 million, up 3.3% versus EUR 569.4 million in FY 2
Galderma Announces Triple Approval of New State-of-the-Art Restylane® Syringe in the EU, the U.S., and Canada, Reaffirming the Company’s Position at the Forefront of Injectable Aesthetics25.2.2026 07:00:00 CET | Press release
Regulatory authorities in the European Union (EU), the United States (U.S.), and Canada have approved a new state-of-the-art Restylane®syringe for use with a range of Restylane NASHA® lidocaine products in multiple indications in the face and in the hands1-3 Developed in collaboration with aesthetic practitioners, its innovative ergonomic design features a cushioned finger grip and thumb rest, to improve practitioner experience through better injection comfort and control, helping them deliver consistently premium results 4-7 The syringe’s carton packaging is the first in the industry to be made from 100% recyclable paper, and reaffirms Galderma’s commitment to sustainability and environmental responsibility 8 These approvals demonstrate Galderma’s strong heritage in Injectable Aesthetics, and its commitment to continuing to drive innovation in the field Galderma (SIX: GALD), today announced that regulatory authorities in the EU, the U.S., and Canada have approved a new state-of-the-ar
Azafaros Announces Publication of Preclinical Efficacy Data with Nizubaglustat in GM2 Gangliosidosis25.2.2026 07:00:00 CET | Press release
Preclinical proof-of-concept data in GM2 gangliosidosis demonstrated survival benefit, functional improvement and target engagementResults are published in the 7 January issue of the Journal of Inherited Metabolic DiseaseNizubaglustat is currently in Phase 3 registrational studies in GM1/GM2 gangliosidoses and Niemann-Pick type C disease (NPC) Azafaros, a company aiming to become a leader in lysosomal storage disorders (LSDs), focused on addressing especially neurological symptoms, today announced the publication of proof-of-concept preclinical data with its lead product, nizubaglustat, in GM2 gangliosidosis. The data, published in the 7 January issue of the Journal of Inherited Metabolic Disease in collaboration with the laboratory of Dr. Jagdeep Walia, Department of Pediatrics, Queen's University, Kingston, Canada, reinforce nizubaglustat’s potential to address unmet needs in rare LSDs and build on existing preclinical and clinical evidence. The preclinical study tested nizubaglustat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
